StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3037% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Long-lived assets — United States (U.S.) by Year

Long-lived assets — United States (U.S.) ($M) ($M)

Vertex Pharmaceuticals Long-lived assets — United States (U.S.): $2,888M in FY2025, up 20.7% from a year earlier. That is the highest of the 16 years on record here.

Latest, FY2025
2,888
Period ended Dec 31, 2025
Change on a year earlier
+20.7%
2,392 in FY2024
History
16 years
Since FY2010
Sources
14
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-13) ↗

Reported in Form 10-K Segment & Geographic Information Note.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLong-lived assets — United States (U.S.) ($M) ($M)Year on yearSource
FY2025Dec 31, 20252,888+20.7%Form 10-K (filed 2026-02-13) ↗
FY2024Dec 31, 20242,392+76.0%Form 10-K (filed 2026-02-13) ↗
FY2023Dec 31, 20231,360-0.4%Form 10-K (filed 2025-02-13) ↗
FY2022Dec 31, 20221,366+1.3%Form 10-K (filed 2024-02-15) ↗
FY2021Dec 31, 20211,348+11.6%Form 10-K (filed 2023-02-10) ↗
FY2020Dec 31, 20201,208+57.1%Form 10-K (filed 2022-02-09) ↗
FY2019Dec 31, 2019769-1.2%Form 10-K (filed 2021-02-11) ↗
FY2018Dec 31, 2018778+3.3%Form 10-K (filed 2020-02-13) ↗
FY2017Dec 31, 2017753+13.2%Form 10-K (filed 2019-02-13) ↗
FY2016Dec 31, 2016666+0.6%Form 10-K (filed 2018-02-15) ↗
FY2015Dec 31, 2015661-2.3%Form 10-K (filed 2017-02-23) ↗
FY2014Dec 31, 2014677+3.0%Form 10-K (filed 2015-02-13) ↗
FY2013Dec 31, 2013658+64.4%Form 10-K (filed 2014-02-11) ↗
FY2012Dec 31, 2012400+265.4%Form 10-K (filed 2013-03-01) ↗
FY2011Dec 31, 2011110+96.9%Form 10-K (filed 2013-03-01) ↗
FY2010Dec 31, 201055.6–Form 10-K (filed 2012-02-22) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals Long-lived assets — United States (U.S.) ($M), annual FY2010–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/geo-lla-us

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.